Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-11-004889
Filing Date
2011-08-09
Accepted
2011-08-09 17:26:59
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 AKORN, INC. 10-Q a6822082.htm 10-Q 981389
2 EXHIBIT 31.1 a6822082ex31-1.htm EX-31.1 9987
3 EXHIBIT 31.2 a6822082ex31-2.htm EX-31.2 10449
4 EXHIBIT 32.1 a6822082ex32-1.htm EX-32.1 5229
5 EXHIBIT 32.2 a6822082ex32-2.htm EX-32.2 5222
  Complete submission text file 0001157523-11-004889.txt   3627706

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT akrx-20110630.xml EX-101.INS 531525
7 XBRL TAXONOMY EXTENSION SCHEMA akrx-20110630.xsd EX-101.SCH 14530
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akrx-20110630_cal.xml EX-101.CAL 41738
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akrx-20110630_def.xml EX-101.DEF 19432
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE akrx-20110630_lab.xml EX-101.LAB 184146
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akrx-20110630_pre.xml EX-101.PRE 103694
Mailing Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045
Business Address 1925 W. FIELD COURT, SUITE 300 LAKE FOREST IL 60045 8472796100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32360 | Film No.: 111021999
SIC: 2834 Pharmaceutical Preparations